Iron Deficiency Anemia

Introduction

Introduction to Iron Metabolism and Iron-Deficiency Anemia

Iron is an essential micronutrient critical for numerous biological processes, including oxygen transport, DNA synthesis, and cellular respiration. Its metabolism is tightly regulated to balance absorption, storage, and utilization while preventing toxicity. Iron-deficiency anemia (IDA) arises when iron supply is insufficient to meet the demands of erythropoiesis, leading to microcytic hypochromic anemia. Understanding the biochemical pathways of iron metabolism is fundamental to diagnosing and managing IDA effectively.

Scope of Iron Metabolism

Iron metabolism encompasses dietary absorption, systemic transport, cellular uptake, storage, and recycling. Key proteins such as transferrin, ferritin, and hepcidin orchestrate these processes. Disruptions in any of these pathways—whether due to dietary insufficiency, malabsorption, or chronic blood loss—can lead to iron deficiency and subsequent anemia. This topic explores the biochemical foundations of iron homeostasis and its clinical implications.

Study

Dietary Iron Absorption

Dietary iron exists in two forms: heme iron (derived from hemoglobin and myoglobin in animal products) and non-heme iron (found in plant-based foods). Heme iron is absorbed more efficiently via the heme carrier protein 1 (HCP1) in duodenal enterocytes. Non-heme iron, primarily in the ferric (Fe³⁺) state, must be reduced to ferrous (Fe²⁺) iron by duodenal cytochrome b (Dcytb) before transport via divalent metal transporter 1 (DMT1). Absorption is regulated by body iron stores, with increased uptake occurring in iron-deficient states.

Systemic Iron Transport and Storage

Once absorbed, iron is exported from enterocytes into the bloodstream via ferroportin, the only known iron exporter. In plasma, iron binds to transferrin, a glycoprotein that delivers it to tissues, particularly erythroid precursors in the bone marrow. Excess iron is stored in ferritin, a multimeric protein complex primarily found in hepatocytes and macrophages. Ferritin sequesters iron in a non-toxic form, releasing it as needed for metabolic processes. The balance between transferrin-bound iron and ferritin storage is critical for maintaining iron homeostasis.

Regulation of Iron Homeostasis by Hepcidin

Hepcidin, a peptide hormone synthesized in the liver, is the central regulator of systemic iron metabolism. It binds to ferroportin, inducing its internalization and degradation, thereby inhibiting iron export from enterocytes, macrophages, and hepatocytes. Hepcidin expression is upregulated by iron overload and inflammation (via IL-6) and downregulated by iron deficiency, hypoxia, and erythropoietic demand. Dysregulation of hepcidin—such as in hereditary hemochromatosis or anemia of chronic disease—can lead to iron overload or functional iron deficiency, respectively.

Iron Recycling and Erythropoiesis

Approximately 90% of daily iron requirements are met through recycling from senescent red blood cells (RBCs) by macrophages in the spleen, liver, and bone marrow. Heme oxygenase-1 degrades hemoglobin, releasing iron for reuse. This recycled iron is either stored in ferritin or exported via ferroportin to support erythropoiesis. In iron-deficiency anemia, impaired iron recycling and reduced transferrin saturation limit hemoglobin synthesis, leading to the production of small, pale RBCs (microcytosis and hypochromia).

Biochemical Consequences of Iron Deficiency

Iron deficiency impairs the activity of iron-dependent enzymes, including those involved in the electron transport chain (e.g., cytochromes) and DNA synthesis (e.g., ribonucleotide reductase). In erythroid precursors, insufficient iron disrupts heme synthesis, leading to the accumulation of protoporphyrin IX and the incorporation of zinc instead of iron into protoporphyrin (forming zinc protoporphyrin). Clinically, this manifests as fatigue, pallor, and reduced oxygen-carrying capacity. Laboratory findings include low serum ferritin, decreased transferrin saturation, and elevated total iron-binding capacity (TIBC).

Summary

Key Takeaways

Iron metabolism is a tightly regulated process involving absorption, transport, storage, and recycling. Key proteins such as transferrin, ferritin, and hepcidin maintain iron homeostasis. Iron-deficiency anemia results from insufficient iron availability for erythropoiesis, leading to microcytic hypochromic RBCs. Understanding these pathways is essential for diagnosing and treating iron-related disorders.

Clinical Correlate

Iron-deficiency anemia is the most common nutritional deficiency worldwide, often caused by chronic blood loss (e.g., menstrual or gastrointestinal bleeding), malabsorption (e.g., celiac disease), or increased demand (e.g., pregnancy). Diagnosis relies on laboratory findings such as low serum ferritin, elevated TIBC, and microcytic anemia. Treatment involves addressing the underlying cause and iron supplementation, with intravenous iron reserved for severe cases or malabsorption.

Pathophysiological Insights

Hepcidin dysregulation plays a central role in the pathogenesis of anemia of chronic disease, where inflammation upregulates hepcidin, trapping iron in macrophages and reducing its availability for erythropoiesis. Conversely, hepcidin deficiency in hereditary hemochromatosis leads to unchecked iron absorption and tissue iron overload. These examples highlight the importance of hepcidin as a therapeutic target in iron-related disorders.